دورية أكاديمية

Stand Up to Cancer Phase Ib Study of Pan-Phosphoinositide- 3-Kinase Inhibitor Buparlisib With Letrozole in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-NegativeMetastatic Breast Cancer.

التفاصيل البيبلوغرافية
العنوان: Stand Up to Cancer Phase Ib Study of Pan-Phosphoinositide- 3-Kinase Inhibitor Buparlisib With Letrozole in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-NegativeMetastatic Breast Cancer.
المؤلفون: Mayer, Ingrid A., Abramson, Vandana G., Isakoff, Steven J., Forero, Andres, Balko, Justin M., Kuba, María Gabriela, Sanders, Melinda E., Yap, Jeffrey T., Van den Abbeele, Annick D., Yisheng Li, Cantley, Lewis C., Winer, Eric, Arteaga, Carlos L.
المصدر: Journal of Clinical Oncology; 4/20/2014, Vol. 32 Issue 12, p1202-1209, 9p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.2013.54.0518